Immuno-based botulinum toxin serotype A activity assays | Patent Publication Number 20210340229
US 20210340229 A1Patent NumberUS 11332518 B2
Application Number17376416
Filled DateJul 15, 2021
Priority DateMar 14, 2008
Publication DateNov 4, 2021
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsD. Dianne Hodges
Patton E. Garay
Lina Wong
Joanne Wang
Lina S. Wong
Patton Garay
Ester Fernandez-Salas
D. Diane Hodges
Kei Roger Aoki
Patton E. Garay
Lina Wong
Joanne Wang
Lina S. Wong
Patton Garay
Ester Fernandez-Salas
D. Diane Hodges
Kei Roger Aoki
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.